<VariationArchive RecordType="classified" VariationID="1803232" VariationName="NM_000277.3(PAH):c.60+2del" VariationType="Deletion" Accession="VCV001803232" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-06-10" DateCreated="2022-12-17" MostRecentSubmission="2022-12-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1860261" VariationID="1803232">
      <GeneList>
        <Gene Symbol="PAH" FullName="phenylalanine hydroxylase" GeneID="5053" HGNC_ID="HGNC:8582" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="102836889" stop="102958441" display_start="102836889" display_stop="102958441" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="103232103" stop="103311380" display_start="103232103" display_stop="103311380" Strand="-" />
          </Location>
          <OMIM>612349</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000277.3(PAH):c.60+2del</Name>
      <CanonicalSPDI>NC_000012.12:102917068:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="102917069" stop="102917069" display_start="102917069" display_stop="102917069" variantLength="1" positionVCF="102917068" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="103310847" stop="103310847" display_start="103310847" display_stop="103310847" variantLength="1" positionVCF="103310846" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.103310847del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.103310847del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.102917069del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.102917069del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008690.2" sequenceAccession="NG_008690" sequenceVersion="2" change="g.46342del">
            <Expression>NG_008690.2:g.46342del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354304.2" sequenceAccession="NM_001354304" sequenceVersion="2" change="c.60+2del">
            <Expression>NM_001354304.2:c.60+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000277.3" sequenceAccession="NM_000277" sequenceVersion="3" change="c.60+2del" MANESelect="true">
            <Expression>NM_000277.3:c.60+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000277.3(PAH):c.60+2del AND Phenylketonuria" Accession="RCV002466902" Version="1">
        <ClassifiedConditionList TraitSetID="159">
          <ClassifiedCondition DB="MedGen" ID="C0031485">Phenylketonuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-17" MostRecentSubmission="2022-12-17">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="159" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3795" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Phenylketonurias</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Phenylketonuria</ElementValue>
                <XRef ID="Phenylketonuria/5714" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009861" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oligophrenia phenylpyruvica</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Folling disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PKU</ElementValue>
                <XRef Type="MIM" ID="261600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Phenylalanine hydroxylase (PAH) deficiency results in intolerance to the dietary intake of the essential amino acid phenylalanine and produces a spectrum of disorders. The risk of adverse outcome varies based on the degree of PAH deficiency. Without effective therapy, most individuals with severe PAH deficiency, known as classic PKU, develop profound and irreversible intellectual disability. Affected individuals on an unrestricted diet who have phenylalanine levels above normal but below 1,200 Âµmol/L (20 mg/dL) are at much lower risk for impaired cognitive development in the absence of treatment.</Attribute>
                <XRef ID="NBK1504" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000596351" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505064" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260641" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330994" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505124" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506557" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529346" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507953" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529111" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000560957" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301677</ID>
                <ID Source="BookShelf">NBK1504</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2008">
                <ID Source="pmc">2267416</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21915151</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24385074</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="pmc">3918542</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Camp et al., 2014">
                <ID Source="PubMed">24667081</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2022">
                <URL>https://managementguidelines.net/guidelines.php/136/PKU%20Nutrition%20Guidelines/Version%202.5</URL>
                <CitationText>PKU Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Phenylalanine.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated Phenylalanine, Phenylalanine hydroxylase deficiency (PAH), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Phenylalanine-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, PAH deficiency: Elevated Phenylalanine, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Adult-PKU.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Adult Genetics Disease ACT Sheet, Adult Phenylketonuria (PKU), 2012</CitationText>
              </Citation>
              <XRef ID="716" DB="Orphanet" />
              <XRef ID="C0031485" DB="MedGen" />
              <XRef ID="MONDO:0009861" DB="MONDO" />
              <XRef Type="MIM" ID="261600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5403595" SubmissionDate="2022-12-14" DateLastUpdated="2022-12-17" DateCreated="2022-12-17">
        <ClinVarSubmissionID localKey="sa_pathology/molecular_genetics_frome_rd/vc16086" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002761783" DateUpdated="2022-12-17" DateCreated="2022-12-17" Type="SCV" Version="1" SubmitterName="Genetics and Molecular Pathology, SA Pathology" OrgID="506043" OrganizationCategory="laboratory" OrgAbbreviation="GMP-FMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_7698</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000277.2:c.60+2delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0009861" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_37</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5403595" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0009861" MappingRef="MONDO">
        <MedGen CUI="C0031485" Name="Phenylketonuria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

